Cell2in Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
20
- Latest Deal Type
-
Out of Business
Cell2in General Information
Description
Operator of a biopharmaceutical research and development center intended to safely measure the glutathione level in living cells. The company provides an unprecedented cell quality control method with potential applications in cell culture, cell therapy manufacturing, and diagnostics of various age-related diseases, enabling scientists to measure the quality of therapeutic cells.
Contact Information
Website
cell2in.comCorporate Office
- 14th floor, 190, Yulgok-ro
- Jongro-gu
- Seoul, 03127
- South Korea
Corporate Office
- 14th floor, 190, Yulgok-ro
- Jongro-gu
- Seoul, 03127
- South Korea
Cell2in Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Out of Business | 18-Aug-2025 | Completed | Out of Business | |||
| 9. Early Stage VC (Series A) | 01-Nov-2020 | Completed | Generating Revenue | |||
| 8. Grant | 01-May-2020 | Completed | Generating Revenue | |||
| 7. Grant | 01-Aug-2019 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 01-Dec-2018 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Aug-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Sep-2016 | $448.68 | $448.68 | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2016 | $2.54K | Completed | Generating Revenue |
Cell2in Patents
Cell2in Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025063804-A1 | Canine placenta-derived mesenchymal stem cells and use thereof | Inactive | 19-Sep-2023 | ||
| US-20240021292-A1 | Method of caring for psychological status based on biometric information and apparatus for performing the same | Active | 11-Feb-2022 | ||
| EP-4269606-A1 | Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same | Inactive | 22-Dec-2020 | ||
| EP-4269606-A4 | Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same | Inactive | 22-Dec-2020 | ||
| US-20250164484-A1 | Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same | Pending | 22-Dec-2020 | G01N33/56966 |
Cell2in Signals
Cell2in FAQs
-
When was Cell2in founded?
Cell2in was founded in 2016.
-
Where is Cell2in headquartered?
Cell2in is headquartered in Seoul, South Korea.
-
What is the size of Cell2in?
Cell2in has 20 total employees.
-
What industry is Cell2in in?
Cell2in’s primary industry is Drug Discovery.
-
Is Cell2in a private or public company?
Cell2in is a Private company.
-
What is Cell2in’s current revenue?
The current revenue for Cell2in is .
-
How much funding has Cell2in raised over time?
Cell2in has raised $3.24K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process